Swiss National Bank raised its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 2.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,119 shares of the medical instruments supplier’s stock after buying an additional 500 shares during the period. Swiss National Bank owned about 0.13% of ICU Medical worth $4,506,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. increased its holdings in shares of ICU Medical by 87,088.7% during the first quarter. BlackRock Inc. now owns 1,769,930 shares of the medical instruments supplier’s stock worth $270,268,000 after buying an additional 1,767,900 shares in the last quarter. Janus Capital Management LLC increased its holdings in shares of ICU Medical by 178.8% during the first quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after buying an additional 923,395 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of ICU Medical by 12.1% during the first quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock worth $99,697,000 after buying an additional 70,283 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in shares of ICU Medical by 4.6% during the first quarter. Champlain Investment Partners LLC now owns 496,220 shares of the medical instruments supplier’s stock worth $75,773,000 after buying an additional 21,630 shares in the last quarter. Finally, GW&K Investment Management LLC increased its holdings in shares of ICU Medical by 2.7% during the second quarter. GW&K Investment Management LLC now owns 495,697 shares of the medical instruments supplier’s stock worth $85,508,000 after buying an additional 12,808 shares in the last quarter. 78.13% of the stock is owned by institutional investors.

In related news, CEO Vivek Jain sold 69,014 shares of the stock in a transaction that occurred on Friday, July 7th. The shares were sold at an average price of $171.10, for a total value of $11,808,295.40. Following the completion of the transaction, the chief executive officer now owns 110,925 shares of the company’s stock, valued at approximately $18,979,267.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Scott E. Lamb sold 23,772 shares of the stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the completion of the transaction, the chief financial officer now directly owns 9,050 shares of the company’s stock, valued at approximately $1,538,681. The disclosure for this sale can be found here. In the last three months, insiders sold 213,012 shares of company stock valued at $36,438,659. 15.90% of the stock is owned by insiders.

A number of analysts recently weighed in on the stock. BidaskClub lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Sidoti lowered shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price target for the company in a report on Thursday, July 20th. Finally, Gabelli reissued a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $193.00.

Shares of ICU Medical, Inc. (NASDAQ ICUI) opened at 184.90 on Friday. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 74.05 and a beta of 0.36. ICU Medical, Inc. has a one year low of $123.77 and a one year high of $186.00. The company has a 50 day moving average of $173.09 and a 200-day moving average of $164.39.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). The company had revenue of $331.51 million during the quarter, compared to the consensus estimate of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. ICU Medical’s revenue for the quarter was up 242.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.15 EPS. On average, analysts expect that ICU Medical, Inc. will post $4.11 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “ICU Medical, Inc. (ICUI) Stake Increased by Swiss National Bank” was reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/09/23/icu-medical-inc-icui-stake-increased-by-swiss-national-bank.html.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.